ardeparin

Known as: ardeparin [Chemical/Ingredient] 
 

Topic mentions per year

Topic mentions per year

1994-2016
02419942016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
BACKGROUND The optimal duration of prophylaxis against venous thromboembolism after total hip or knee replacement is uncertain… (More)
Is this relevant?
1999
1999
In addition to its anticoagulant effects, heparin is known to have antiproliferative effects on vascular smooth muscle cells… (More)
Is this relevant?
1998
1998
BACKGROUND Ardeparin sodium has recently received approval by the Food and Drug Administration for prophylaxis against venous… (More)
  • table 1
  • table 2
  • table 5
  • table 3
  • table 4
Is this relevant?
1997
1997
UNLABELLED We performed a double-blind, randomized clinical trial to compare the efficacy and safety of three different… (More)
Is this relevant?
1997
1997
Ardeparin sodium (Normiflo, Wyeth-Ayerst) is a low molecular weight heparin undergoing clinical evaluation as an antithrombotic… (More)
Is this relevant?
1996
1996
BACKGROUND Deep vein thrombosis is common in patients undergoing major knee surgery. Static graduated compression stockings… (More)
Is this relevant?
1995
1995
Ardeparin is a low molecular weight heparin currently being evaluated as an antithrombotic agent. The objective of this… (More)
Is this relevant?
1995
1995
This prospective, uncontrolled trial explored the relationship between varying dosages of a low molecular weight heparin (LMWH… (More)
Is this relevant?
1995
1995
Osteoporosis is a well-recognized complication of long-term heparin use. However, the mechanisms by which heparin can influence… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
1994
1994
We have compared the non-specific binding of unfractionated heparin (UFH) with that of low molecular weight heparin (LMWH) to… (More)
Is this relevant?